The group of Dr. Kerstin Bartscherer currently has a vacancy for a PhD student To work on Cellular and molecular characterization of regenerating spiny mouse tissues.

Description of the project:
The regeneration of lost body parts is one of the most fascinating processes in nature. African spiny mice are among the few mammals capable of regenerating large parts of their skin. We use these animals to understand successful tissue regeneration in mammals and, through comparative approaches, the roadblocks that prevent this process in most other species. The student will use powerful new sequencing technologies in combination with cell and molecular biology methods to characterize regeneration in spiny mice.

We are looking for highly motivated, outstanding students with an MSc degree in one of the life sciences and strong previous training in cell and molecular biology. The candidates should have experience with or at least an interest in computational methods for the analysis of RNAseq data. Willingness to work with mice is a must. The working language in our international team is English, the candidate should therefore have excellent English communication skills and be able to work as part of an interdisciplinary team.

Duration:
1 year with the possibility of an extension for three years after positive evaluation.

Starting date:
Preferably October 2018

Salary:
According to “CAO-Nederlandse Universiteiten” (CAO-NU) € 2.266,- in the first year, increasing to € 2.897,- in the fourth year, excluding 8% holiday allowance and an 8,3% year-end bonus. We offer an extensive package of fringe benefits.

Hubrecht Institute

The Hubrecht Institute – an Academy research institute – focused on developmental and stem cell biology. It encompasses 20 research groups that perform fundamental and multidisciplinary research, both in healthy systems and disease models. Since 2008, the institute is affiliated with the University Medical Center Utrecht, advancing the translation of research to the clinic. The Hubrecht Institute has a partnership with the UMC Utrecht, Utrecht University, Princess Máxima Center for pediatric oncology, the European Molecular Biology Laboratory (EMBL) and Oncode Institute.